CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-07 | Paolini John F. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −200 | $27.00 | $5K | 57,403 |
| 2025-05-07 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise · Share Option 10b5-1 | −200 | 65,867 | ||
| 2025-05-07 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +229 | $8.83 | $2K | 32,775 |
| 2025-05-07 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +2,998 | $15.50 | $46K | 35,773 |
| 2025-05-07 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +14,420 | $11.97 | $173K | 50,193 |
| 2025-05-07 | Megna Michael R CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −17,647 | $26.69 | $471K | 32,546 |
| 2025-05-07 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Share Option 10b5-1 | −229 | 0 | ||
| 2025-05-07 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Share Option 10b5-1 | −2,998 | 16,002 | ||
| 2025-05-07 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Share Option 10b5-1 | −14,420 | 17,040 | ||
| 2025-05-05 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise 10b5-1 | +6,272 | $17.76 | $111K | 15,687 |
| 2025-05-05 | Moat Ross CHIEF COMMERCIAL OFFICER | Sale 10b5-1 | −6,272 | $28.00 | $176K | 9,415 |
| 2025-05-05 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise · Share Option 10b5-1 | −6,272 | 27,389 | ||
| 2025-05-02 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise 10b5-1 | +3,850 | $17.76 | $68K | 13,265 |
| 2025-05-02 | Moat Ross CHIEF COMMERCIAL OFFICER | Sale 10b5-1 | −3,850 | $28.00 | $108K | 9,415 |
| 2025-05-02 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise · Share Option 10b5-1 | −3,850 | 33,661 | ||
| 2025-05-01 | Moat Ross CHIEF COMMERCIAL OFFICER | Grant or award · Performance Share Unit 10b5-1 | +4,976 | 4,976 | ||
| 2025-05-01 | Moat Ross CHIEF COMMERCIAL OFFICER | Grant or award · Performance Share Unit 10b5-1 | +5,225 | 5,225 | ||
| 2025-05-01 | Moat Ross CHIEF COMMERCIAL OFFICER | Grant or award · Performance Share Option 10b5-1 | +8,043 | 8,043 | ||
| 2025-05-01 | Moat Ross CHIEF COMMERCIAL OFFICER | Grant or award · Performance Share Option 10b5-1 | +8,303 | 8,303 | ||
| 2025-05-01 | Tessari Eben CHIEF OPERATING OFFICER | Grant or award · Performance Share Unit | +4,975 | 4,975 |
Page 34 of 74 · 1,467 trades